KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBIT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.99%
Dec 31, 2025 7.68%
Sep 30, 2025 -4.89%
Jun 30, 2025 125.47%
Mar 31, 2025 -49.03%
Dec 31, 2024 12.90%
Sep 30, 2024 7.23%
Jun 30, 2024 92.63%
Mar 31, 2024 -22.03%
Dec 31, 2023 -37.11%
Sep 30, 2023 -24.70%
Jun 30, 2023 39.72%
Mar 31, 2023 -13.86%
Dec 31, 2022 -16.17%
Sep 30, 2022 22.24%
Jun 30, 2022 -12.96%
Mar 31, 2022 8.51%
Dec 31, 2021 -3.11%
Sep 30, 2021 187.20%
Jun 30, 2021 -61.11%
Mar 31, 2021 6.03%
Dec 31, 2020 -18.14%
Sep 30, 2020 5.60%
Jun 30, 2020 -1.36%
Mar 31, 2020 14.99%
Dec 31, 2019 -17.29%
Sep 30, 2019 -7.54%
Jun 30, 2019 8.33%
Mar 31, 2019 3.78%
Dec 31, 2018 2.54%
Sep 30, 2018 -17.97%
Jun 30, 2018 3.89%
Mar 31, 2018 21.43%
Dec 31, 2017 -7.95%
Sep 30, 2017 -9.60%
Jun 30, 2017 4.13%
Mar 31, 2017 4.27%
Dec 31, 2016 -1.66%
Sep 30, 2016 6.18%
Jun 30, 2016 -0.92%
Mar 31, 2016 18.15%
Dec 31, 2015 -13.08%
Sep 30, 2015 12.67%
Jun 30, 2015 2.67%
Mar 31, 2015 38.59%
Dec 31, 2014 -0.48%
Sep 30, 2014 -22.92%
Jun 30, 2014 39.44%
Mar 31, 2014 14.91%
Dec 31, 2013 -29.68%
Sep 30, 2013 8.90%
Jun 30, 2013 7.49%
Mar 31, 2013 32.54%
Dec 31, 2012 -23.54%
Sep 30, 2012 -10.45%
Jun 30, 2012 7.58%
Mar 31, 2012 27.11%
Dec 31, 2011 121.33%
Sep 30, 2011 -60.59%
Jun 30, 2011 3.02%
Mar 31, 2011 21.07%
Dec 31, 2010 -27.79%
Sep 30, 2010 -2.50%
Jun 30, 2010 2.43%
Mar 31, 2010 31.88%
Dec 31, 2009 -30.03%
Sep 30, 2009 10.16%
Jun 30, 2009 10.30%